Quaker Chemical

KWRNYSEUSD

THESIS ALERT

Email me when the KWR thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$155.91
+$1.54 (+1.00%)Today 1M −1.01%
After hours$155.910.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$154.37
Prior regular-session close from the quote source.
$153.22–$156.10
Regular-session low and high so far today.
70.3K
Regular-session shares traded · Nov 11, 4:00 PM ET.
Feb 22 projected
Projected for 2027-02-22 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$112.18–$183.01
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own KWR if its process-fluid expertise keeps customers from commoditizing the product, but the 2025 profit collapse makes margin normalization—not simple revenue growth—the key test.

KWR price history

Latest price$155.91Today+$1.54 (+1.00%)
KWR -0.44%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Quaker’s embedded role in customers’ industrial production processes should make demand more resilient than a commodity chemical supplier, provided customers still value technical performance and continuity over switching to cheaper alternatives.HoldingMateriality: High

    GAAP annual revenue remained in a narrow range: $1.94 billion in FY2022, $1.95 billion in FY2023, $1.84 billion in FY2024, and $1.89 billion in FY2025. If this holds, Quaker has a durable base to monetize through pricing and service; if it breaks, revenue becomes cyclical and price-led.

    Watch: Large steel, aluminum, automotive, or other industrial customers standardize on lower-cost fluids from Fuchs, Henkel, Castrol/BP, or regional blenders.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual revenue remained in a narrow range: $1.94 billion in FY2022, $1.95 billion in FY2023, $1.84 billion in FY2024.

    Open source ↗
  • Quaker’s specialty formulation and service model should preserve pricing power through raw-material cycles, unless customers begin treating its products as substitutable commodity inputs.HoldingMateriality: High

    GAAP annual gross profit increased from $612.7 million in FY2022 to $705.6 million in FY2023. Gross-profit resilience is the clearest evidence that Quaker is being paid for value rather than merely passing through input costs.

    Watch: A sharp oil, additive, or specialty-chemical feedstock cost spike cannot be passed through in customer contracts.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual gross profit increased from $612.7 million in FY2022 to $705.6 million in FY2023.

    Open source ↗
  • The investment case requires Quaker’s global scale and cost discipline to translate stable gross profit into operating income; otherwise the service-heavy model becomes an expense burden rather than a moat.WeakeningMateriality: Medium

    GAAP annual operating income was $214.5 million in FY2023 and $194.7 million in FY2024, showing the model can produce substantial operating profit when execution is working. This is the bridge from a good product franchise to shareholder value; if operating conversion does not recover, stable sales are not enough.

    Watch: Persistent restructuring, integration, impairment, or corporate-cost issues keep operating expenses elevated even when gross profit is stable.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating income was $214.5 million in FY2023 and $194.7 million in FY2024, showing the model can produce substantial.

    Open source ↗
  • Quaker’s recurring consumables business should generate enough operating cash through the cycle to fund operations and protect the balance sheet, provided working capital and customer collections do not absorb the economics.HoldingMateriality: Medium

    GAAP annual operating cash flow was positive in each supplied year: $41.8 million in FY2022, $279.0 million in FY2023, $204.6 million in FY2024, and $136.5 million in FY2025. Positive cash conversion gives the company time to fix margins; weak cash conversion would turn an earnings problem into a financial-flexibility problem.

    Watch: Industrial customers stretch payment terms or destock aggressively, tying up cash in receivables and inventory.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating cash flow was positive in each supplied year: $41.8 million in FY2022, $279.0 million in FY2023, $204.6.

    Open source ↗
  • Quaker’s global employee and service footprint should reinforce customer stickiness by supporting local technical problem-solving, unless competitors can match that service density at lower cost.HoldingMateriality: Medium

    The company had approximately 4,700 full-time employees globally as of the latest supplied profile date. The service layer is what can separate Quaker from commodity chemical suppliers; if it weakens, pricing power and retention are at risk.

    Watch: Fuchs, Henkel, Castrol/BP, or local competitors win plant-level programs by offering comparable technical support with lower total cost.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    The company had approximately 4,700 full-time employees globally as of the latest supplied profile date.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Quaker’s embedded role in customers’ industrial production processes should make demand more resilient than a commodity chemical supplier, provided customers still value technical performance and continuity over switching to cheaper alternatives. If this holds, Quaker has a durable base to monetize through pricing and service; if it breaks, revenue becomes cyclical and price-led.

Quaker’s specialty formulation and service model should preserve pricing power through raw-material cycles, unless customers begin treating its products as substitutable commodity inputs. Gross-profit resilience is the clearest evidence that Quaker is being paid for value rather than merely passing through input costs.

The investment case requires Quaker’s global scale and cost discipline to translate stable gross profit into operating income; otherwise the service-heavy model becomes an expense burden rather than a moat. This is the bridge from a good product franchise to shareholder value; if operating conversion does not recover, stable sales are not enough.

Quaker’s recurring consumables business should generate enough operating cash through the cycle to fund operations and protect the balance sheet, provided working capital and customer collections do not absorb the economics. Positive cash conversion gives the company time to fix margins; weak cash conversion would turn an earnings problem into a financial-flexibility problem.

Quaker’s global employee and service footprint should reinforce customer stickiness by supporting local technical problem-solving, unless competitors can match that service density at lower cost. The service layer is what can separate Quaker from commodity chemical suppliers; if it weakens, pricing power and retention are at risk.

All standing thesis claims
Original report summary

its process-fluid expertise keeps customers from commoditizing the product, but the 2025 profit collapse makes margin normalization—not simple revenue growth—the key test.

Evidence assessed Oct 15, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Quaker Chemical

Where the evidence on Quaker Chemical disagrees: Mixed on the latest evidence (Oct 15, 2026). Of its 5 thesis points, 4 holding and 1 weakening.

Bull case: what the evidence supports

  • Quaker’s embedded role in customers’ industrial production processes should make demand more resilient than a commodity chemical supplier, provided customers still value technical performance and continuity over switching to cheaper alternatives.

    sec.gov ↗

  • Quaker’s specialty formulation and service model should preserve pricing power through raw-material cycles, unless customers begin treating its products as substitutable commodity inputs.

    sec.gov ↗

  • Quaker’s recurring consumables business should generate enough operating cash through the cycle to fund operations and protect the balance sheet, provided working capital and customer collections do not absorb the economics.

    sec.gov ↗

  • Quaker’s global employee and service footprint should reinforce customer stickiness by supporting local technical problem-solving, unless competitors can match that service density at lower cost.

    sec.gov ↗

Bear case: what the evidence questions

  • The investment case requires Quaker’s global scale and cost discipline to translate stable gross profit into operating income; otherwise the service-heavy model becomes an expense burden rather than a moat.

    sec.gov ↗

Thesis-Break Engine

What has broken in Quaker Chemical’s thesis

Each break OptimistFi flagged on Quaker Chemical, dated — with what has historically followed the same kind of break across the market, not a forecast for Quaker Chemical.

peers+15%-20%-2%12 mo agonow+6 mo
Daily price, then where similar breaks led across the market: the typical -2% path vs comparable companies over six months, inside the middle-half range (+15% to -20%). A base rate, not a forecast.
  • CEO / officer changecondition set before this filing

    Across all companies, this kind of break has happened 16,849 times before. Those stocks trailed comparable companies by a median of 2% over the next six months, and 38% of them trailed it by 10 points or more.

Several kinds of break have stacked on Quaker Chemical at once. A cluster is a stronger read than any one signal alone.

How the Thesis-Break Engine works →Historical outcomes are measured against comparable companies after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Entered a material definitive agreement.

    Quaker Chemical filed an SEC 8-K on 2026-10-01: Entered a material definitive agreement. It is a dated development that tests the current thesis.

  2. Mixed
    Director or principal officer change.

    Quaker Chemical filed an SEC 8-K on 2026-09-08: Director or principal officer change. It is a dated development that tests the current thesis.

  3. Mixed
    Reported results of operations (earnings release).

    Quaker Chemical filed an SEC 8-K on 2026-07-30: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Large steel, aluminum, automotive, or other industrial customers standardize on lower-cost fluids from Fuchs, Henkel, Castrol/BP, or regional blenders.
  • A sharp oil, additive, or specialty-chemical feedstock cost spike cannot be passed through in customer contracts.
  • Persistent restructuring, integration, impairment, or corporate-cost issues keep operating expenses elevated even when gross profit is stable.
  • Industrial customers stretch payment terms or destock aggressively, tying up cash in receivables and inventory.
  • Fuchs, Henkel, Castrol/BP, or local competitors win plant-level programs by offering comparable technical support with lower total cost.

KWR news

Loading headlines…

Financial statements

KWR income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

KWR: quick answers

When does Quaker Chemical (KWR) report earnings next?
Quaker Chemical's next results are projected for February 22, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on October 29, 2026. Earnings calendar
What is KWR's short interest?
As of October 30, 2026, 1.6M KWR shares were sold short, 9.58% of its shares outstanding, down 4.5% from the count before. At the stock's average daily volume that is 11 days to cover. FINRA publishes the count twice a month. KWR short interest history
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.